Migdal Insurance & Financial Holdings’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-255
Closed -$4K 713
2021
Q4
$4K Sell
255
-154
-38% -$3.08K ﹤0.01% 657
2021
Q3
$8K Buy
+409
New +$10.6K ﹤0.01% 615

Other funds holding RNLX

Migdal Insurance & Financial Holdings's RNLX Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2022, closing a stake of 255 shares — an estimated $4K sold.

Migdal Insurance & Financial Holdings first reported a position in RNLX in Q3 2021 and held it in 2 quarters. The position peaked at $8K in Q3 2021. 35 funds tracked by Wall St. Rank hold RNLX as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Renalytix plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 255 Renalytix plc American Depositary Shares shares in Q1 2022, an estimated $4K.
  • Migdal Insurance & Financial Holdings first reported a position in Renalytix plc American Depositary Shares in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Renalytix plc American Depositary Shares position peaked at $8K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.